Insulin Glargine Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

    The worldwide Insulin Glargine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period.

    This report presents the market size and development trends by detailing the Insulin Glargine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Insulin Glargine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Insulin Glargine industry and will help you to build a panoramic view of the industrial development.

    Insulin Glargine Market, By Type:

    • Single Dose Vial

    • Pre-filled Syringe

    Insulin Glargine Market, By Application:

    • Treat type 1 diabetes

    • Treat type 2 diabetes

    Some of the leading players are as follows:

    • Ganlee

    • Sanofi-Aventis

    • Biocon

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Insulin Glargine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Single Dose Vial

      • 1.3.2 Pre-filled Syringe

    • 1.4 Market Segment by Application

      • 1.4.1 Treat type 1 diabetes

      • 1.4.2 Treat type 2 diabetes

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Insulin Glargine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Insulin Glargine by Major Types

      • 3.4.1 Single Dose Vial

      • 3.4.2 Pre-filled Syringe

    4 Segmentation of Insulin Glargine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Insulin Glargine by Major End-Users

      • 4.4.1 Treat type 1 diabetes

      • 4.4.2 Treat type 2 diabetes

    5 Market Analysis by Major Regions

    • 5.1 Global Insulin Glargine Production Analysis by Top Regions

    • 5.2 Global Insulin Glargine Consumption Analysis by Top Regions

    • 5.3 Global Insulin Glargine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Insulin Glargine Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Insulin Glargine Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Insulin Glargine Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Insulin Glargine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Insulin Glargine Market among Top Countries

    • 6.1 Top 5 Export Countries in Insulin Glargine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Insulin Glargine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Insulin Glargine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Insulin Glargine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Insulin Glargine Landscape Analysis

    • 7.1 North America Insulin Glargine Landscape Analysis by Top Countries

      • 7.1.1 United States Insulin Glargine Market Volume and Growth Rate

      • 7.1.2 Canada Insulin Glargine Market Volume and Growth Rate

      • 7.1.3 Mexico Insulin Glargine Market Volume and Growth Rate

    8. Europe Insulin Glargine Landscape Analysis

    • 8.1 Europe Insulin Glargine Landscape Analysis by Major Types

    • 8.2 Europe Insulin Glargine Landscape Analysis by Major End-Users

    • 8.3 Europe Insulin Glargine Landscape Analysis by Top Countries

      • 8.3.1 Germany Insulin Glargine Market Volume and Growth Rate

      • 8.3.2 UK Insulin Glargine Market Volume and Growth Rate

      • 8.3.3 France Insulin Glargine Market Volume and Growth Rate

      • 8.3.4 Italy Insulin Glargine Market Volume and Growth Rate

      • 8.3.5 Spain Insulin Glargine Market Volume and Growth Rate

      • 8.3.6 Belgium Insulin Glargine Market Volume and Growth Rate

      • 8.3.7 Poland Insulin Glargine Market Volume and Growth Rate

      • 8.3.8 Russia Insulin Glargine Market Volume and Growth Rate

      • 8.3.9 Turkey Insulin Glargine Market Volume and Growth Rate

      • 8.3.10 Netherlands Insulin Glargine Market Volume and Growth Rate

      • 8.3.11 Portugal Insulin Glargine Market Volume and Growth Rate

      • 8.3.12 Denmark Insulin Glargine Market Volume and Growth Rate

      • 8.3.13 Finland Insulin Glargine Market Volume and Growth Rate

      • 8.3.14 Iceland Insulin Glargine Market Volume and Growth Rate

      • 8.3.15 Norway Insulin Glargine Market Volume and Growth Rate

      • 8.3.16 Sweden Insulin Glargine Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Insulin Glargine Landscape Analysis

    • 9.1 Asia Pacific Insulin Glargine Landscape Analysis by Top Countries

      • 9.1.1 China Insulin Glargine Market Volume and Growth Rate

      • 9.1.2 Japan Insulin Glargine Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Insulin Glargine Market Volume and Growth Rate

      • 9.1.4 India Insulin Glargine Market Volume and Growth Rate

      • 9.1.5 ASEAN Insulin Glargine Market Volume and Growth Rate

      • 9.1.6 South Korea Insulin Glargine Market Volume and Growth Rate

    10 LAMEA Insulin Glargine Landscape Analysis

    • 10.1 LAMEA Insulin Glargine Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Insulin Glargine Market Volume and Growth Rate

      • 10.1.2 Brazil Insulin Glargine Market Volume and Growth Rate

      • 10.1.3 North Africa Insulin Glargine Market Volume and Growth Rate

      • 10.1.4 South Africa Insulin Glargine Market Volume and Growth Rate

      • 10.1.5 Argentina Insulin Glargine Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Ganlee

      • 11.1.1 Ganlee Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sanofi-Aventis

      • 11.2.1 Sanofi-Aventis Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Biocon

      • 11.3.1 Biocon Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 82 Figures and 204 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Single Dose Vial

    • Figure Market Size and Growth Rate of Pre-filled Syringe

    • Figure Market Size and Growth Rate of Treat type 1 diabetes

    • Figure Market Size and Growth Rate of Treat type 2 diabetes

    • Figure North America Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure United States Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure France Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure China Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure India Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Insulin Glargine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Insulin Glargine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Insulin Glargine by Different Types from 2014 to 2026

    • Table Consumption Share of Insulin Glargine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Single Dose Vial

    • Figure Market Size and Growth Rate of Pre-filled Syringe

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Insulin Glargine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Insulin Glargine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Treat type 1 diabetes

    • Figure Market Size and Growth Rate of Treat type 2 diabetes

    • Table Global Insulin Glargine Production by Major Regions

    • Table Global Insulin Glargine Production Share by Major Regions

    • Table Global Insulin Glargine Consumption by Major Regions

    • Table Global Insulin Glargine Consumption Share by Major Regions

    • Table North America Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table Europe Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table LAMEA Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Insulin Glargine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Insulin Glargine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table North America Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Insulin Glargine Consumption Share by Major Countries in 2014

    • Figure North America Insulin Glargine Consumption Share by Major Countries in 2018

    • Figure North America Insulin Glargine Consumption Share by Major Countries in 2026

    • Figure United States Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Insulin Glargine Consumption by Types from 2014 to 2026

    • Table Europe Insulin Glargine Consumption Share by Types from 2014 to 2026

    • Table Europe Insulin Glargine Consumption by End-Users from 2014 to 2026

    • Table Europe Insulin Glargine Consumption Share by End-Users from 2014 to 2026

    • Table Europe Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table Europe Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure France Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure China Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure India Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ganlee

    • Figure Sales and Growth Rate Analysis of Ganlee

    • Figure Revenue and Market Share Analysis of Ganlee

    • Table Product and Service Introduction of Ganlee

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis

    • Table Product and Service Introduction of Sanofi-Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.